Thoughts About K4D (Free subscription) | 07/27/2008
Source: "," The Economist, July 24th 2008.There have been a number of recent mergers, resulting in a consolidation of the industry producing generic pharmaceuticals. The mergers have veen international, affecting firms headquartered in Israel and India as well as in Europe and the United States. The generic drug market "enjoyed $72 billion in sales last year, and is growing faster than the conventional...
MSDN Blogs (Free subscription) | 07/22/2008
While many still debate the value and appropriateness of Extension Methods in C# 3.0, I have always felt that there was still something missing. Extension methods allow me to add individual methods to classes; however, there are several cases where I have always wanted to add a new interface to a class that is sealed and outside my control. For lack of a better term, I would consider these an "Extension...
Inbox Robot: Swiss Reinsurance News (Free subscription) | 07/20/2008
The Economic Times ( 17th July 2008) Congressional committee is set to investigate whether the US Food and Drug Administration ( FDA) knowingly allowed Indian generic pharma ...
PR News Wire (Free subscription) | 07/14/2008
Branded Pharmaceutical companies can expect to see sales drops of up to 70 percent after patent expiration from Generic competition NEW YORK, LONDON and TOKYO, July 14 /PRNewswire/ -- Branded Pharmaceutical companies are painfully aware of the astronomical growth of Generics competition. By the end of this year, Branded drug patents accounting for sales of more than $80 Billion will expire, resulting...
My Two Dollars (Free subscription) | 8 hours ago
Prescription drug prices are heading up, just like almost anything else that we all depend on in our daily lives. I am lucky in that our new plan has Generics for $2, but many people still pay hundreds, if not thousands, each month for their medicine. But with a little digging and a little work, [...]
PortlandOnline (Free subscription) | 07/10/2008
PDF Document, 2,171kb Category: Caremark Pharmacy Benefit
Health Business Blog (Free subscription) | 07/09/2008 | Other
It’s that time of year again: when Blue Cross Blue Shield of Massachusetts sends the annual health insurance renewal notice for my boutique health care consulting firm. This year’s increase is 13.3 percent, on top of last year’s 26.3 percent increase and an 11 percent increase the year before. Thanks to the magic of compounding [...]
IPBiz (Free subscription) | 07/06/2008
Speaking of the recent acquisition of Ranbaxy, the Economic Times noted: For Indian companies, the challenges in product patent regime, in the Generics business are significant: margin pressure, legal issues, parallel launch of authorised Generics, accessing the distribution channels and so on. Margin pressures continue to rise in the regulated international generic markets, because of a host of factors,...
Doc's Talk (Free subscription) | 08/18/2008
Raymond Ibrahim Regarding the whole "Words Matter" issue, and how U.S. governmental agencies are dropping theologically-laden words from the lexicon -- which the Danes are sadly emulating -- some time back, one Peter Singer wrote a NY Times piece arguing that dropping such words in favor of Generics, such as "terrorists" or "extremists," is, in fact, a brilliant idea, to which I responded to in American...
Paramus Post (Free subscription) | 06/28/2008
A PLACE IN YOUR CART A visit to the supermarket is becoming almost as painful as a trip to the gas pump. Anyone who does the family grocery shopping knows that food prices are soaring at a rate that hasn't been seen in decades. For the first three months of 2008, grocery store food prices rose at a 5.9 percent seasonally adjusted rate, after a 4.9 percent increase in all of 2007, according to the...
Pharmalot (Free subscription) | 06/26/2008
Hard to say. But at the very end of a recent - and, unfortunately, not very revealing - interview at The Wharton School, Bill Weldon hints that Generics aren’t being ruled out. Sure, the J&J ceo talks about being a research company and brags that pharma is about 40 percent of revenue these days. But his pharma division has issues with restrictions on Procrit and generating interest in its Invega follow-up...
Jihad Watch (Free subscription) | 08/17/2008
Regarding the whole "Words Matter" issue, and how U.S. governmental agencies are dropping theologically-laden words from the lexicon -- which the Danes are sadly emulating -- some time back, one Peter Singer wrote a NY Times piece arguing that dropping...
Tim Anderson's ITWriting (Free subscription) | 08/13/2008
Today I viewed David Intersimone’s Live Webinar on what’s new in Delphi 2009, code-named Tiburon. This is a Win32-only release. I think you will want it (if you use Delphi), if only for the new language-level features: Generics, anonymous methods, and unicode strings. I grabbed a few screens from the presentation. Generics: Unicode – here’s the [...]
Lazy Man and Money (Free subscription) | 08/14/2008
Clipping coupons may pay off after all One of the universal tenants of Lazy Man and Money is, well, laziness. I try to find ways that I can maximize my dollar without sacrificing quality - or at least finding a good balance in value for my dollar. One of the things that I’ve been [...]
Shooting the Kids (Free subscription) | 08/15/2008
Digital Photography Blogs highlights some of the better photographic deals of the week. This week: Canon Loyalty Program, Flash Diffusers for Under $4, Canon 50mm f1.8 II Lens, Canon Powershot A590IS, Lensbaby, and Epson Stylus Photo 1400.
